| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 25, 2025 5:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 25, 2025 5:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
3 - Wellgistics Health, Inc. (0002030763) (Issuer)
3 - Wellgistics Health, Inc. (0002030763) (Issuer)
4 - Wellgistics Health, Inc. (0002030763) (Issuer)
8-K - Wellgistics Health, Inc. (0002030763) (Filer)
PRE 14C - Wellgistics Health, Inc. (0002030763) (Filer)
8-K - Wellgistics Health, Inc. (0002030763) (Filer)
BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- DataVault AI, Inc. ("DataVault") (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts ("PharmacyChain™") into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry. The goal of the partnership will be to seek to fully digitize t
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a growing force in pharmaceutical distribution and healthcare technology, will appear live on YouTube via the Floorstocks channel (@floorstocks) this Tuesday, July 22 at 1:00 PM EST. CEO Brian Norton will participate in an unfiltered discussion covering WGRX's recent momentum, stock performance, market outlook, and the company's strategy ahead. Floorstocks—the platform known for amplifying rising public companies—will host this live session, providing retail investors direct engagement. Why Tune In? Hear firsthand insight from CEO Brian Norton on the company's latest developmentsDeep dive into WGRX
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health Inc. (NASDAQ:WGRX). The full interview is now available on YouTube and Floorstocks.com, offering investors a front-row look at one of healthcare's most disruptive emerging growth companies. Watch the full interview on YouTube:https://youtu.be/gJJlbqd7Mv8 Also streaming at Floorstocks.com:https://www.floorstocks.com Hosted by market veteran Kenneth Polcari, the interview unpacks how Wellgistics is modernizing the $600+ billion U.S. prescription
Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity
Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity